Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.02 per share, down from $4.20 per share in the year-ago period. Vertex Pharmaceuticals projects quarterly ...

The S&P 500 Index ($SPX) (SPY) today is up +0.39%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.25%, and the Nasdaq ...

The S&P 500 Index ($SPX) (SPY) today is up +0.73%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.35%. March E-mini S&P futures (ESH25) are ...

Truist Financial analyst Joon Lee maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s shares closed ...

The bull market in global equities continued to modestly grind ahead in the 2nd quarter. Click here to read the full ...

In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report), with ...

Unite Us, the nation’s leading technology partner for social care transformation, will be featured in an upcoming segment on Viewpoint with Dennis Quaid. The documentary will spotlight Unite Us’ ...

In the meantime, the gap, or spread, between LME and COMEX futures prices has widened to $740 a tonne, its highest in around ...

Wall Street also benefited from some dip-buying after clocking steep falls on Friday, as Trump flagged plans to impose tariffs on U.S. imports to match levies from U.S. trading partners on goods ...

Sticky inflation provides the Fed with little impetus to cut interest rates - a trend highlighted by the central bank in January, when it kept interest rates unchanged. Analysts and Federal Reserve ...